Page last updated: 2024-09-03
cki 7 and (R)-DRF053
cki 7 has been researched along with (R)-DRF053 in 1 studies
Compound Research Comparison
Studies (cki 7) | Trials (cki 7) | Recent Studies (post-2010) (cki 7) | Studies ((R)-DRF053) | Trials ((R)-DRF053) | Recent Studies (post-2010) ((R)-DRF053) |
---|---|---|---|---|---|
35 | 0 | 7 | 7 | 0 | 6 |
Protein Interaction Comparison
Protein | Taxonomy | cki 7 (IC50) | (R)-DRF053 (IC50) |
---|---|---|---|
Glycogen synthase kinase-3 beta | Sus scrofa (pig) | 4.1 | |
[Tau protein] kinase | Sus scrofa (pig) | 4.1 | |
Cyclin-T1 | Homo sapiens (human) | 8 | |
Cyclin-dependent kinase 1 | Homo sapiens (human) | 1.96 | |
G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | 1.96 | |
Cyclin-A2 | Homo sapiens (human) | 0.29 | |
G1/S-specific cyclin-E1 | Homo sapiens (human) | 0.093 | |
Cyclin-dependent kinase 2 | Homo sapiens (human) | 0.1915 | |
Casein kinase I isoform alpha | Homo sapiens (human) | 0.014 | |
Cyclin-dependent kinase 7 | Homo sapiens (human) | 0.822 | |
Cyclin-dependent kinase 9 | Homo sapiens (human) | 8 | |
Cyclin-H | Homo sapiens (human) | 0.822 | |
CDK-activating kinase assembly factor MAT1 | Homo sapiens (human) | 0.822 | |
Cyclin-dependent-like kinase 5 | Homo sapiens (human) | 0.1475 | |
Cyclin-dependent kinase 5 activator 1 | Homo sapiens (human) | 0.1475 |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Feng, S; Ji, P; Li, GB; Ma, S; Sun, QZ; Wang, ZR; Yan, HX; Yang, LL; Yang, SY; Zou, J | 1 |
Other Studies
1 other study(ies) available for cki 7 and (R)-DRF053
Article | Year |
---|---|
Discovery of N6-phenyl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamine derivatives as novel CK1 inhibitors using common-feature pharmacophore model based virtual screening and hit-to-lead optimization.
Topics: Casein Kinase I; Diamines; Dose-Response Relationship, Drug; Drug Discovery; High-Throughput Screening Assays; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Pyrimidines; Structure-Activity Relationship | 2012 |